Pharmacokinetics of Mycophenolate Mofetil in de novo lung allograft recipients
Phase of Trial: Phase III
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Lung transplant rejection
- Focus Pharmacokinetics; Registrational
- Acronyms CELMACS
- Sponsors Roche
- 07 Jul 2012 Last checked against European Clinical Trials Database record.
- 06 Jun 2012 Status changed from active, no longer recruiting to completed, according to EudraCT record.
- 18 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.